Skip to main content
    N

    Novocure Ltd (NVCR)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NASDAQ

    $11.14
    -0.16 (-1.42%)

    Market Cap: $1.38B

    Last updated: Nov 17, 2026 at 4:20 PM ET

    Novocure Ltd (NVCR) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Novocure (NVCR) has a market cap of $1.38B and an enterprise value of $1.48B. Its share count is up 4.36% from a year earlier. It kept -16.78% of revenue as net income over the last 12 months.

    Total Valuation

    Enterprise value is 7.20% above the market cap, as debt exceeds cash.

    Market Cap$1.38B
    Enterprise Value$1.48B
    Latest price (Nov 17, 2026)$11.14

    Key Dates

    Last Earnings DateOct 29, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count rose 0.67% in the quarter ended Sep 30, 2026 and grew 3.87% a year over 2 years.

    Shares Outstanding116.79M
    Shares Change (YoY)+4.36%
    Shares Change (QoQ)+0.67%
    Share Count Growth (2Y CAGR)+3.87%

    Valuation Ratios

    Sales and book value multiples are 1.8x and 3.7x. Its year-end P/S ranged from 2.2x to 36.2x from 2016 to 2025.

    P/S Ratio1.8x
    Forward P/S1.9x
    P/B Ratio3.7x

    Valuation history and multiples

    Price Statistics

    The stock is down 1.59% over 52 weeks and trades 23.65% below its 50-day average.

    Beta (1Y)1.52
    52-Week Change-1.59%
    1-Month Change-25.18%
    3-Month Change-38.79%
    6-Month Change-34.51%
    5-Year Change-87.18%
    10-Year Change+117.36%
    Total Return (1Y)-1.59%
    Total Return (3Y CAGR)-3.43%
    Total Return (5Y CAGR)-36.62%
    Return vs SPY (1Y)-14.27%
    Max Drawdown (1Y)-44.27%
    Max Drawdown (3Y)-69.98%
    Sharpe Ratio (1Y)-0.04
    Correlation with SPY (1Y)0.27
    50-Day Average$14.59
    200-Day Average$14.78
    52-Week Range$9.82 to $21.45
    RSI (14 Days)29.9
    Average Volume (20 Days)1.96M

    The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 2.49x current liabilities, and total debt is 0.56x shareholder equity.

    Current Ratio2.49x
    Quick Ratio2.34x
    Debt / Equity0.56x

    Returns and Efficiency

    Return on invested capital is -21.23% over the last 12 months, against a 5-year average of -23.50%.

    Return on Equity (ROE)-34.72%
    Return on Assets (ROA)-14.69%
    Return on Invested Capital (ROIC)-21.23%
    Return on Capital Employed (ROCE)-22.32%
    ROE (5Y Average)-35.83%
    ROA (5Y Average)-12.30%
    ROIC (5Y Average)-23.50%
    Asset Turnover0.66x
    Inventory Turnover4.03x
    Receivables Turnover7.00x
    Cash Conversion Cycle-160 days

    Scores

    NVCR has an Altman Z-Score of 0.25, in the distress zone below 1.81, and a Piotroski F-Score of 3 of 9, in the average band of 3 to 7.

    Altman Z-Score0.25
    Altman Z ZoneDistress
    Piotroski F-Score3 of 9
    Piotroski StrengthAverage

    Income Statement

    Revenue of $725.39M over the last 12 months is up 12.94% from the 12 months before.

    Revenue$725.39M
    Revenue Growth (YoY)+12.94%
    Gross Profit$558.67M
    Operating Income-$124.55M
    Pretax Income-$130.54M
    Net Income-$121.73M
    EBITDA-$119.05M
    EBIT-$124.55M
    Reported EPS (TTM)-$1.06

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 42.31% of the $828.71M in total assets.

    Cash and Equivalents$96.73M
    Total Debt$196.34M
    Net Debt$99.60M
    Net Debt Per Share$0.85
    Working Capital$402.86M
    Shareholder Equity$350.61M
    Book Value Per Share$3.00
    Total Assets$828.71M
    Total Liabilities$478.10M

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    After $23.89M of capital spending, operating cash flow left -$24.61M of free cash flow.

    Operating Cash Flow-$722.00K
    Capital Expenditures$23.89M
    Free Cash Flow-$24.61M
    FCF Per Share-$0.21
    Depreciation and Amortization$28.63M

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Margins

    The operating margin is -17.17%, against a 5-year average of -24.46%.

    Gross Margin77.02%
    Operating Margin-17.17%
    Pretax Margin-18.00%
    Net Margin-16.78%
    EBITDA Margin-16.41%
    EBIT Margin-17.17%
    FCF Margin-3.39%
    Gross Margin (5Y Average)76.77%
    Operating Margin (5Y Average)-24.46%
    Net Margin (5Y Average)-23.48%

    Growth

    Revenue grew 6.81% a year over 3 years.

    Revenue Growth (3Y CAGR)+6.81%
    Revenue Growth (5Y CAGR)+5.80%
    Book Value Per Share Growth (2Y CAGR)-5.06%
    Tangible Book Per Share Growth (2Y CAGR)-5.06%

    Revenue and profit by year

    Dividends and Yields

    NVCR does not pay a dividend. Its free cash flow yield is -1.89%.

    FCF Yield-1.89%
    Buyback Yield-0.28%
    Shareholder Yield-0.28%

    Peer Position

    Against 12 similar companies, NVCR has the 8th highest P/S.

    P/S Ratio1.8x vs 1.9x median
    ROIC-21.23% vs -3.43% median
    Revenue Growth (Trailing 4 Quarters, YoY)+12.94% vs +10.41% median

    Competitors compared

    Analyst Forecast

    Consensus estimates put revenue growth at 11.12% a year over the next 2 fiscal years.

    Revenue Growth Forecast (2Y CAGR)+11.12%

    Analyst estimates by year

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    GNG Valuation

    GNG viewUndervalued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About NVCR

    What is NVCR's market cap?

    Novocure has a market cap of $1.38B. Its enterprise value, which adds debt and subtracts cash, is $1.48B.

    How many shares of NVCR are outstanding?

    Novocure has 116.79M shares outstanding. The count is up 4.36% from a year earlier.

    Does NVCR pay a dividend?

    No. Novocure does not pay a dividend.

    How much debt does NVCR have?

    Novocure has $196.34M of total debt and $96.73M of cash and equivalents, a net debt position of $99.60M.